Study Reveals How Extrachromosomal DNA Drives Oncogene Evolution in Glioblastoma Tumors
By
PaulHoule
Crackles when you bite it. Shows the baker did the work.
Summary
This scientific study investigates how extrachromosomal DNA (ecDNA) drives oncogene spatial heterogeneity and evolution in glioblastoma. Researchers analyzed 94 treatment-naive human glioblastomas and found that ecDNA-amplified oncogenes follow specific evolutionary patterns, with EGFR-ecDNAs often accumulating before clonal expansions and conferring strong fitness advantages. The study reveals that variant EGFR-ecDNAs (like EGFRvIII) always derive from preexisting wild-type EGFR-ecDNAs and occur early in tumor development, suggesting ecDNA's oncogenic makeup determines unique evolutionary trajectories in brain cancer.
Key quotes
· 5 pulledOncogenes amplified on extrachromosomal DNA (ecDNA) contribute to treatment resistance and poor survival across cancers
EGFR-ecDNAs often accumulate prior to clonal expansions, conferring strong fitness advantages and reaching high abundances
Variant and wild-type EGFR-ecDNAs often coexist in GBM. Those variant EGFR-ecDNAs, most commonly EGFRvIII-ecDNA, always derive from preexisting wild-type EGFR-ecDNAs
Our results suggest that the ecDNA oncogenic makeup determines unique evolutionary trajectories
ecDNA accumulation can precede clonal expansion, facilitating the emergence of EGFR oncogenic variants, reframing our interpretation of genomic data
You might also wanna read
Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·9h ago
Nutrigenomics framework identifies vitamin B3 as potential therapy for NAXD deficiency disorder
This article presents a nutrigenomics framework that systematically identifies monogenic diseases that can be treated with vitamin supplemen
Are Cancer Rates Actually Rising, or Are We Just Detecting Them Earlier?
The article discusses the perception of rising cancer rates and questions whether they are actually increasing or if improved detection meth
share.google·4d ago
Multi-omics and single-cell CRISPRi screening maps Alzheimer's GWAS variants to TSPAN14 effector gene in microglia
This study presents a variant-to-gene (V2G) mapping effort for Alzheimer disease (AD) that integrates ten brain-relevant genomics datasets—i
KAIST researchers discover molecular switch that can reverse cancer cell transformation at transition point
KAIST Professor Kwang-Hyun Cho's research team has discovered a molecular switch in the genetic network that can reverse cancerous transform
ecancer.org·4d ago
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks
bit.ly·4h ago